Reappraisal of Antihypertensive Medicine Doxazosin and Carvedilol as a Potential Therapeutic for Hepatic Fibrosis

por Paik, Yong-Han
Publicado en Gut Liver (2016)

NADPH oxidase mediated oxidative stress in hepatic fibrogenesis

por Paik, Yong-Han, Brenner, David A.
Publicado 2011

Are patients with alcohol-related fatty liver at increased risk of coronary heart disease?

por Sinn, Dong Hyun, Paik, Yong-Han
Publicado 2014

Toll-Like Receptor Signaling and Liver Fibrosis

por Aoyama, Tomonori, Paik, Yong-Han, Seki, Ekihiro
Publicado 2010

ROLE OF GUT MICROBIOTA IN LIVER DISEASE

por Brenner, David A., Paik, Yong-Han, Schnabl, Bernd
Publicado en J Clin Gastroenterol (2015)

Assessment of Hepatic Fibrosis Regression by Transient Elastography in Patients with Chronic Hepatitis B Treated with Oral Antiviral Agents

por Kim, Ja Kyung, Ma, Dae Won, Lee, Kwan Sik, Paik, Yong-Han
Publicado 2014

A case of Alagille syndrome presenting with chronic cholestasis in an adult

por Kim, Jihye, Yang, Bumhee, Paik, Namyoung, Choe, Yon Ho, Paik, Yong-Han
Publicado en Clin Mol Hepatol (2017)

The Diagnostic Value of Endoprobe for Small Esophageal Leiomyomas Derived from the Muscularis Mucosae

por Lee, Se-Joon, Paik, Yong-Han, Lee, Dong-Ki, Lee, Kwan-Sik, Lee, Sang-In
Publicado 2005

Role of NADPH Oxidases in Liver Fibrosis

por Paik, Yong-Han, Kim, Jonghwa, Aoyama, Tomonori, De Minicis, Samuele, Bataller, Ramon, Brenner, David A.
Publicado 2014

NADPH Oxidase 1 and NADPH Oxidase 4 Have Opposite Prognostic Effects for Patients with Hepatocellular Carcinoma after Hepatectomy

por Ha, Sang Yun, Paik, Yong-Han, Yang, Jung Wook, Lee, Min Ju, Bae, Hyunsik, Park, Cheol-Keun
Publicado en Gut Liver (2016)

The Nicotinamide Adenine Dinucleotide Phosphate Oxidase Homologues NOX1 and NOX2/gp91(phox) Mediate Hepatic Fibrosis in Mice

por Paik, Yong-Han, Iwaisako, Keiko, Seki, Ekihiro, Inokuchi, Sayaka, Schnabl, Bernd, Österreicher, Christoph H., Kisseleva, Tatiana, Brenner, David A.
Publicado 2011

Migration of Fibrocytes in Fibrogenic Liver Injury

por Scholten, David, Reichart, Donna, Paik, Yong Han, Lindert, Jens, Bhattacharya, Jahar, Glass, Christopher K., Brenner, David A., Kisseleva, Tatiana
Publicado 2011

Proline-rich tyrosine kinase 2 mediates transforming growth factor-beta-induced hepatic stellate cell activation and liver fibrosis

por Kim, Jonghwa, Kang, Wonseok, Kang, So Hee, Park, Su Hyun, Kim, Ji Young, Yang, Sera, Ha, Sang Yun, Paik, Yong-Han
Publicado en Sci Rep (2020)

Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma

por Sohn, Won, Kim, Jonghwa, Kang, So Hee, Yang, Se Ra, Cho, Ju-Yeon, Cho, Hyun Chin, Shim, Sang Goon, Paik, Yong-Han
Publicado en Exp Mol Med (2015)

Alteration of Interferon-α/β Receptors in Chronic Hepatitis B Patients

por Meng, Fanli, Wang, Jiefei, Ge, Jian, Fan, Xiaopeng, Wang, Bing, Han, Liyan, Kisseleva, Tatiana, Paik, YongHan, Brenner, David A., Wang, Kai
Publicado en J Clin Immunol (2011)

The comparison of esophageal variceal ligation plus propranolol versus propranolol alone for the primary prophylaxis of esophageal variceal bleeding

por Je, Dongmo, Paik, Yong-Han, Gwak, Geum-Youn, Choi, Moon Seok, Lee, Joon Hyeok, Koh, Kwang Cheol, Paik, Seung Woon, Yoo, Byung Chul
Publicado 2014

Feasibility of α-fetoprotein as a diagnostic tool for hepatocellular carcinoma in Korea

por Ahn, Dae Geon, Kim, Hyung Joon, Kang, Hyun, Lee, Hyun Woong, Bae, Si Hyun, Lee, Joon Hyoek, Paik, Yong Han, Lee, June Sung
Publicado en Korean J Intern Med (2016)

Risk score model for the development of hepatocellular carcinoma in treatment-naïve patients receiving oral antiviral treatment for chronic hepatitis B

por Sohn, Won, Cho, Ju-Yeon, Kim, Ji Hoon, Lee, Jung Il, Kim, Hyung Joon, Woo, Min-Ah, Jung, Sin-Ho, Paik, Yong-Han
Publicado en Clin Mol Hepatol (2017)

Hepatic resection vs percutaneous radiofrequency ablation of hepatocellular carcinoma abutting right diaphragm

por Song, Kyoung Doo, Lim, Hyo Keun, Rhim, Hyunchul, Lee, Min Woo, Kang, Tae Wook, Paik, Yong Han, Kim, Jong Man, Joh, Jae-Won
Publicado en World J Gastrointest Oncol (2019)

A Phase II Study of Capecitabine Combined with Gemcitabine in Patients with Advanced Gallbladder Carcinoma

por Cho, Jae-Yong, Nam, Ji-Sun, Park, Mi-Suk, Yu, Jeong-Sik, Paik, Yong-Han, Lee, Se-Joon, Lee, Dong-Ki, Yoon, Dong-Sup
Publicado 2005